Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,0611,080 of 20,252 grants

Active NON-SBIR/STTR RPGS
Identification of Covalent Transcriptional Dependencies in Melanoma
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Advances in human genetics have identified 400+ genes that when amplified or mutated promote tumorigenesis. While there has been substantial success in dev...

$6.98M
USD
Active NON-SBIR/STTR RPGS
Interoception and Obesogenic Eating Behaviors in Children
NATIONAL CANCER INSTITUTE Pennsylvania State University, The United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Obesity is a key risk factor for several types of cancer. Development of healthy weight and eating behaviors during childhood has the potential to reduce c...

$4.12M
USD
Active SBIR-STTR RPGS
Controlling Tumor Immune Escape in Pancreatic Cancer using a Dual T Cell Product Strategy
NATIONAL CANCER INSTITUTE Marker Therapeutics, Inc United States 2024 – 2026

ABSTRACT While T cell therapies have shown efficacy in hematologic malignancies, extension of this success to solid tumors has proven to be challenging, mainly due to the immunosup...

$6.51M
USD
Active NON-SBIR/STTR RPGS
The Role of Early Life Exposure to Antibiotics on Risk of Early Onset Colorectal Cancer
NATIONAL CANCER INSTITUTE University of South Carolina At Columbia United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT The incidence of early onset colorectal cancer (EOCRC) has increased in the past four decades and is predicted to increase by 140% by 2030.4,5 It is the se...

$3.72M
USD
Active NON-SBIR/STTR RPGS
Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

PROJECT SUMMARY Metastasis is the primary cause of cancer mortality, yet few breast cancer drugs effectively inhibit metastasis. Breast cancer cells use collective migration to rem...

$4.43M
USD
Active NON-SBIR/STTR RPGS
Targeting microbial triggers of gammopathy for immunoprevention
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2026

Abstract: Multiple myeloma (MM) is an incurable plasma cell tumor preceded by a defined preneoplastic state termed as monoclonal gammopathy of undetermined significance (MGUS). Str...

$7.9M
USD
Active NON-SBIR/STTR RPGS
Efficacy Trial of Healthy Juntos: A Family-based Digital Lifestyle Intervention for Hispanic Adolescents and their Parents
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2024 – 2029

PROJECT SUMMARY Obesity, physical inactivity, and poor diet are major modifiable risk factors for cancer — a leading cause of death among US Hispanics. US Hispanic youth have the h...

$6.5M
USD
Active OTHER RESEARCH-RELATED
Lung fibrosis impairs tumor immunity and limits immune checkpoint efficacy
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT The long-term goal of this proposal is to train the applicant to become an independent, academic physician- scientist studying immune responses against lun...

$2.32M
USD
Completed OTHER RESEARCH-RELATED
Gordon Research Conference (GRC) on Signaling by Adhesion Receptors
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2025

The Gordon Research Conference (GRC) on Signaling by Adhesion Receptors was established in 2000 and has become the premier meeting on cellular adhesion biology, mechanobiology, and...

$150K
USD
Completed SBIR-STTR RPGS
Development of a Novel Immunotherapeutic for Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE Cambium Oncology Llc United States 2024 – 2025

Acute Myeloid Leukemia (AML) and the Need for Advanced Treatment: AML is a prevalent hematological malignancy in adults, with a 5-year survival rate of only 32%. While approximatel...

$4.05M
USD
Active OTHER RESEARCH-RELATED
The Role of Propionate Metabolism in Non-Small Cell Lung Cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2029

Project Summary/Abstract Despite exciting advances, lung cancer remains the leading cause of cancer-related deaths in the United States. A critical gap in our understanding is how...

$1.96M
USD
Completed NON SBIR/STTR CONTRACTS
TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531
NATIONAL CANCER INSTITUTE Iit Research Institute United States 2024 – 2025

The purpose of this work is to perform toxicology studies in rats and dogs in order to prepare compound MTX-531 for IND submission.

$13.39M
USD
Active OTHER RESEARCH-RELATED
Developing a Values Elicitation Tool to Improve Treatment Decision-Making in Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT This NCI K08 Mentored Career Development Award will prepare Dr. Daniel Richardson to become an independent R01-level investigator in patient-centered cance...

$2.85M
USD
Active NON-SBIR/STTR RPGS
Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice (PREDICT)
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

Abstract Cervical cancer is highly preventable when detected early and managed appropriately; today it is most often diagnosed in under-screened individuals or after a failure to f...

$7.24M
USD
Active NON-SBIR/STTR RPGS
Combined Imaging and RNA Analyses to Develop Cervical Cancer Biomarkers
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

TITLE: Combined Imaging and RNA Analyses to Develop Cervical Cancer Biomarkers ABSTRACT Despite significant advances in disease prevention and screening, cervical cancer continues...

$6.61M
USD
Active NON-SBIR/STTR RPGS
Determinants of toxicity and response to immune checkpoint blockade through integrative profiling of T cell clonal dynamics and plasma cell- free DNA
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2029

PROJECT SUMMARY Severe immune-related adverse events (irAEs) occur in up to ~60% of melanoma patients treated with combination (anti-PD1 / anti-CTLA4) immune checkpoint inhibitors...

$7.12M
USD
Active OTHER RESEARCH-RELATED
SPOT-IT: Sepsis Prediction in Oncology Through Implementation Science and Technology
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2024 – 2029

Project Abstract Patients with cancer face unacceptable morbidity and mortality from sepsis, a life-threatening dysregulated response to infection. Oncologic sepsis contributes to...

$2.83M
USD
Active SBIR-STTR RPGS
A parallelized computational microscope platform for high-throughput live imaging of patient-derived organoids
NATIONAL CANCER INSTITUTE Ramona Optics, Inc United States 2024 – 2027

Significance: As a biologically relevant miniaturized model system for human tissues, 3D organoids offer a powerful new platform for high-throughput biomedical research, including...

$4M
USD
Active OTHER RESEARCH-RELATED
Leveraging a community-academic partnership to pilot a family-centered communication intervention for Latinx young adult childhood cancer survivors
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2029

PROJECT SUMMARY Adult survivors of childhood cancer face a lifetime of health risks due to past cancer treatments, with an estimated 80% experiencing at least one severe or life-th...

$2.68M
USD
Active NON-SBIR/STTR RPGS
Targeting cell state transitions driving resistance to KRAS inhibitors in lung cancer
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2029

Lung adenocarcinoma (LUAD), commonly driven by KRAS mutations, is responsible for 7% of all cancer mortality. LUAD predominantly arises from alveolar type 2 (AT2) cells, which func...

$7.36M
USD